Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
279.34
-7.95 (-2.77%)
At close: Apr 28, 2026, 4:00 PM EDT
279.34
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT

Company Description

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications.

This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories.

Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software.

The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers.

Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories logo
Country United States
Founded 1952
Industry Medical Devices
Sector Healthcare
Employees 7,450
CEO Norman Schwartz

Contact Details

Address:
1000 Alfred Nobel Drive
Hercules, California 94547
United States
Phone 510 724 7000
Website bio-rad.com

Stock Details

Ticker Symbol BIO
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000012208
CUSIP Number 090572207
ISIN Number US0905722072
Employer ID 94-1381833
SIC Code 3826

Key Executives

Name Position
Norman D. Schwartz Chairman and Chief Executive Officer
Jonathan P. DiVincenzo President and Chief Operating Officer
Roop K. Lakkaraju CPA Executive Vice President and Chief Financial Officer
James J. Barry Executive Vice President and President of Life Science Group
Rajat Mehta Executive Vice President of Global Commercial Operations
Yong Chung Vice President of Investor Relations
Matthew Werner Senior Vice President and Chief Compliance and Privacy Officer
Courtney C. Enloe Executive Vice President, General Counsel and Secretary
Nanditha R. Yelamanchi Executive Vice President of Global Human Resources
Michael Crowley Executive Vice President of Global Commercial Operations

Latest SEC Filings

Date Type Title
Apr 24, 2026 8-K Current Report
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 25, 2026 ARS Filing
Mar 25, 2026 DEF 14A Other definitive proxy statements
Feb 19, 2026 8-K Current Report
Feb 13, 2026 10-K Annual Report
Feb 12, 2026 8-K Current Report
Dec 2, 2025 144 Filing
Nov 18, 2025 144 Filing
Nov 6, 2025 144 Filing